{
  "id": "NGN_Cloze_2026_BATCH300-191-1771351245451",
  "itemType": "standalone",
  "questionType": "clozeDropdown",
  "caseId": null,
  "seed": "BATCH-300-191-1771351245451",
  "cjjm": "takeActions",
  "difficulty": 4,
  "stem": "The nurse in a neurology clinic receives a call from a 38-year-old client with relapsing-remitting multiple sclerosis (MS). The client reports a 3-day history of increasing numbness in the left leg, right-sided blurred vision, and debilitating fatigue. The nurse suspects an MS relapse.",
  "body": "The nurse is developing a plan of care for this client experiencing a suspected MS relapse. The nurse should anticipate implementing the following orders.\n\nThe client will be scheduled for a(n) **[1]** to confirm new inflammatory activity.\nThe nurse will prepare to administer **[2]** to manage the acute exacerbation.\nThe nurse should educate the client that this medication works by **[3]**.\nTo manage the new-onset fatigue, the nurse should recommend **[4]**.\nThe nurse should also screen the client for **[5]** as a common comorbidity exacerbated by a relapse.",
  "clozeDropdowns": [
    {
      "blankId": "1",
      "options": [
        {
          "id": "opt_1_1",
          "text": "MRI of the brain and spinal cord with gadolinium"
        },
        {
          "id": "opt_1_2",
          "text": "lumbar puncture for CSF analysis"
        },
        {
          "id": "opt_1_3",
          "text": "CT scan of the head without contrast"
        },
        {
          "id": "opt_1_4",
          "text": "evoked potential studies"
        }
      ]
    },
    {
      "blankId": "2",
      "options": [
        {
          "id": "opt_2_1",
          "text": "oral baclofen"
        },
        {
          "id": "opt_2_2",
          "text": "high-dose intravenous methylprednisolone"
        },
        {
          "id": "opt_2_3",
          "text": "a new disease-modifying therapy (DMT)"
        },
        {
          "id": "opt_2_4",
          "text": "plasmapheresis"
        }
      ]
    },
    {
      "blankId": "3",
      "options": [
        {
          "id": "opt_3_1",
          "text": "blocking nerve impulses that cause muscle spasticity"
        },
        {
          "id": "opt_3_2",
          "text": "preventing future relapses over the long term"
        },
        {
          "id": "opt_3_3",
          "text": "suppressing the inflammatory response in the central nervous system"
        },
        {
          "id": "opt_3_4",
          "text": "removing harmful antibodies from the blood plasma"
        }
      ]
    },
    {
      "blankId": "4",
      "options": [
        {
          "id": "opt_4_1",
          "text": "complete bed rest to conserve all energy"
        },
        {
          "id": "opt_4_2",
          "text": "balancing periods of activity with rest"
        },
        {
          "id": "opt_4_3",
          "text": "starting a high-intensity interval training program"
        },
        {
          "id": "opt_4_4",
          "text": "increasing consumption of caffeinated beverages"
        }
      ]
    },
    {
      "blankId": "5",
      "options": [
        {
          "id": "opt_5_1",
          "text": "depression"
        },
        {
          "id": "opt_5_2",
          "text": "urinary tract infection"
        },
        {
          "id": "opt_5_3",
          "text": "hypothyroidism"
        },
        {
          "id": "opt_5_4",
          "text": "seizure activity"
        }
      ]
    }
  ],
  "answer": [
    "opt_1_1",
    "opt_2_2",
    "opt_3_3",
    "opt_4_2",
    "opt_5_1"
  ],
  "answerBreakdown": {
    "findings": [
      {
        "key": "Client Information",
        "value": "38-year-old with relapsing-remitting MS."
      },
      {
        "key": "Symptoms",
        "value": "3-day history of increasing numbness in left leg, right-sided blurred vision, and debilitating fatigue."
      },
      {
        "key": "Suspected Diagnosis",
        "value": "MS relapse (exacerbation)."
      }
    ],
    "rationales": [
      {
        "optionId": "opt_1_1",
        "rationale": "Correct. An MRI of the brain and spinal cord with gadolinium is the gold standard for confirming an MS relapse. Gadolinium enhances active inflammatory lesions, allowing visualization of new demyelination in the central nervous system (CNS). This confirms objective evidence of a new CNS event, differentiating a true relapse from a pseudo-exacerbation.",
        "points": 1
      },
      {
        "optionId": "opt_1_2",
        "rationale": "Incorrect. A lumbar puncture for CSF analysis, specifically looking for oligoclonal bands, is primarily used in the initial diagnosis of MS to support the presence of intrathecal immunoglobulin synthesis. It is not the primary diagnostic tool for confirming an acute relapse in a client with a known MS diagnosis.",
        "points": 0
      },
      {
        "optionId": "opt_1_3",
        "rationale": "Incorrect. CT scans are less sensitive than MRI in visualizing the demyelinating plaques characteristic of MS. MRI is the preferred imaging modality for assessing MS disease activity due to its superior resolution and ability to detect subtle changes in the brain and spinal cord.",
        "points": 0
      },
      {
        "optionId": "opt_1_4",
        "rationale": "Incorrect. Evoked potential studies measure the speed of nerve conduction and can help diagnose MS by demonstrating slowed nerve signals along specific pathways. While useful in the initial diagnosis, they are not the primary tool for confirming an acute, active relapse. MRI is used to visualize active lesions.",
        "points": 0
      },
      {
        "optionId": "opt_2_1",
        "rationale": "Incorrect. Baclofen is a muscle relaxant used to manage chronic spasticity in MS. It does not treat the underlying inflammation associated with an acute relapse. While it can alleviate muscle stiffness, it does not address the primary pathology of the exacerbation.",
        "points": 0
      },
      {
        "optionId": "opt_2_2",
        "rationale": "Correct. High-dose intravenous corticosteroids, such as methylprednisolone, are the first-line treatment for acute MS relapses. These medications reduce inflammation in the CNS by suppressing the immune response and decreasing edema around demyelinated plaques. This can shorten the duration and severity of the relapse by promoting faster recovery of nerve function.",
        "points": 1
      },
      {
        "optionId": "opt_2_3",
        "rationale": "Incorrect. Disease-modifying therapies (DMTs) are used for long-term management to reduce the frequency and severity of future relapses. They do not treat an acute exacerbation. DMTs work by modulating the immune system over time to prevent further damage to myelin.",
        "points": 0
      },
      {
        "optionId": "opt_2_4",
        "rationale": "Incorrect. Plasmapheresis (plasma exchange) is a second-line therapy reserved for severe relapses that do not respond to high-dose corticosteroids. It involves removing harmful antibodies from the blood plasma. It is not the initial intervention due to its invasiveness and potential complications.",
        "points": 0
      },
      {
        "optionId": "opt_3_1",
        "rationale": "Incorrect. This describes the mechanism of action for antispasmodic medications like baclofen, which reduce muscle spasticity by acting on the central nervous system to inhibit nerve impulses. Corticosteroids have a different mechanism of action.",
        "points": 0
      },
      {
        "optionId": "opt_3_2",
        "rationale": "Incorrect. This describes the goal of disease-modifying therapies (DMTs), which modulate the immune system over time to prevent future relapses. Corticosteroids provide short-term, acute anti-inflammatory effects to reduce the severity of the current relapse.",
        "points": 0
      },
      {
        "optionId": "opt_3_3",
        "rationale": "Correct. Corticosteroids like methylprednisolone work by exerting a potent anti-inflammatory and immunosuppressive effect. They reduce edema and inflammation at the sites of demyelination in the CNS, which helps to restore nerve function and alleviate symptoms during an acute MS relapse.",
        "points": 1
      },
      {
        "optionId": "opt_3_4",
        "rationale": "Incorrect. This describes the mechanism of plasmapheresis, which physically removes antibodies and other inflammatory mediators from the blood. It is a more invasive procedure used when corticosteroids are ineffective.",
        "points": 0
      },
      {
        "optionId": "opt_4_1",
        "rationale": "Incorrect. Prolonged bed rest can lead to deconditioning, muscle atrophy, and increased fatigue, which can worsen MS symptoms. It is generally discouraged. Encouraging activity within tolerance is more beneficial.",
        "points": 0
      },
      {
        "optionId": "opt_4_2",
        "rationale": "Correct. Energy conservation is a crucial strategy for managing MS fatigue. This involves planning activities, taking scheduled rest periods, and avoiding overexertion to maintain functional ability. Pacing activities helps prevent overwhelming fatigue and allows for better participation in daily life.",
        "points": 1
      },
      {
        "optionId": "opt_4_3",
        "rationale": "Incorrect. High-intensity exercise can significantly worsen fatigue and other MS symptoms, particularly during an acute relapse. Gentle, graded exercise may be appropriate, but not high-intensity training. Overexertion can exacerbate symptoms and prolong recovery.",
        "points": 0
      },
      {
        "optionId": "opt_4_4",
        "rationale": "Incorrect. While caffeine can provide a temporary boost, overuse can disrupt sleep patterns and lead to a crash, ultimately worsening the cycle of fatigue. It is not a recommended primary management strategy. Consistent sleep hygiene and energy conservation are more effective.",
        "points": 0
      },
      {
        "optionId": "opt_5_1",
        "rationale": "Correct. Depression is a highly prevalent comorbidity in clients with MS. The physical, emotional, and social challenges of a relapse can trigger or worsen depressive symptoms. Routine screening using tools like the Beck Depression Inventory or the Patient Health Questionnaire-9 (PHQ-9) is an essential part of comprehensive nursing care.",
        "points": 1
      },
      {
        "optionId": "opt_5_2",
        "rationale": "Incorrect. A urinary tract infection (UTI) is a common *trigger* for a pseudo-exacerbation (a temporary worsening of symptoms due to infection or fever, not new demyelination). The question asks about screening for a common *comorbidity*, making depression the better answer. While UTIs are important to address, they are not a primary comorbidity.",
        "points": 0
      },
      {
        "optionId": "opt_5_3",
        "rationale": "Incorrect. While autoimmune disorders can co-occur, hypothyroidism is not as common or directly linked to MS exacerbations as depression. The symptoms of MS are more likely to exacerbate mood disorders.",
        "points": 0
      },
      {
        "optionId": "opt_5_4",
        "rationale": "Incorrect. While seizures can occur in clients with MS due to cortical lesions, they are not as common a comorbidity as depression. Screening for mood disorders is a higher priority during a relapse due to the significant impact on quality of life and functional outcomes.",
        "points": 0
      }
    ]
  },
  "scoring": {
    "type": "dichotomous",
    "points": 1,
    "perCloze": true,
    "totalPoints": 5
  },
  "sbar": {
    "situation": "1300: 38-year-old client with relapsing-remitting MS reports a 3-day history of increasing numbness in the left leg, right-sided blurred vision, and debilitating fatigue.",
    "background": "Client has a known diagnosis of MS. Symptoms suggest a possible relapse, characterized by new or worsening neurological deficits.",
    "assessment": "Suspect MS relapse (exacerbation) based on reported symptoms and known diagnosis. Requires further investigation to confirm active demyelination.",
    "recommendation": "Request order for MRI of the brain and spinal cord with gadolinium to confirm active lesions. Anticipate order for high-dose intravenous methylprednisolone. Educate the client on medication action, potential side effects, and energy conservation techniques. Screen for depression using a standardized assessment tool."
  },
  "clinicalPearls": [
    "MRI with gadolinium is the gold standard for confirming MS relapse by visualizing active inflammatory lesions. Gadolinium enhancement indicates breakdown of the blood-brain barrier.",
    "High-dose IV corticosteroids are the first-line treatment for acute MS relapses to reduce inflammation in the CNS. Monitor for side effects such as hyperglycemia, mood changes, and increased risk of infection.",
    "Energy conservation strategies, such as balancing activity with rest, are crucial for managing MS-related fatigue. Encourage the client to prioritize activities and avoid overexertion.",
    "Depression is a common comorbidity in MS clients, and screening is essential, especially during relapses. Untreated depression can significantly impact quality of life and adherence to treatment."
  ],
  "sentinelStatus": "healed_v2026_v8"
}